Age-based outcomes in kidney cancer patients treated with first-line targeted therapy or immunotherapy
This study compared disease outcomes, treatments, and dose reductions in [...]
Moderna vaccine is third vaccine to be approved in the UK
The Moderna COVID-19 vaccine has today been given regulatory approval [...]
What is genetic testing for cancer?
This article gives a good summary of the use of [...]
Active surveillance for young patients with small renal masses
Active surveillance is increasingly being used for the management of [...]
Percutaneous thermoablation for small renal masses
This study looked at the survival of patients suitable for [...]
CB-839/cabozantinib combination in advanced/metastatic kidney cancer fails to improve progression-free survival
The US Food and Drug Administration (FDA) has granted the [...]
Nivolumab plus ipilimumab for first-line treatment of advanced kidney cancer: Extended 4-year follow-up
Four-year follow up data are now available from the CheckMate [...]
Top stories from 2020 for kidney cancer
Dr Sumanta (Monty) Pal, Clinical Professor and Co-Director of the [...]
AstraZeneca/Oxford University’s COVID-19 vaccine UK rollout
AstraZeneca and Oxford University’s COVID-19 vaccine is being rolled out [...]
2020 top stories in kidney cancer
This article summarises the key breakthroughs in the treatment of [...]
